Cited by 77Alzheimer's disease research and treatmentsCellular transport and secretionNeuroinflammation and Neurodegeneration Mechanisms

LDLR-related protein 10 (LRP10) regulates amyloid precursor protein (APP) trafficking and processing: evidence for a role in Alzheimer’s disease

Open access
Brodeur, Julie, Thériault, Caroline, Lessard-Beaudoin, Mélissa, Marcil, Alexandre, Dahan, Sophie, Lavoie, Christine·2012·Molecular Neurodegeneration

Abstract

Background: The Aβ peptide that accumulates in Alzheimer’s disease (AD) is derived from amyloid precursor protein (APP) following proteolysis by β- and γ-secretases. Substantial evidence indicates that alterations in APP trafficking within the secretory and endocytic pathways directly impact the interaction of APP with these secretases and subsequent Aβ production. Various members of the low-density lipoprotein receptor (LDLR) family have been reported to play a role in APP trafficking and processing and are important risk factors in AD. We recently characterized a distinct member of the LDLR family called LDLR-related protein 10 (LRP10) that shuttles between the trans-Golgi Network (TGN), plasma membrane (PM), and endosomes. Here we investigated whether LRP10 participates in APP intracellular trafficking and Aβ production. Results: In this report, we provide evidence that LRP10 is a functional APP receptor involved in APP trafficking and processing. LRP10 interacts directly with the ectodomain of APP and colocalizes with APP at the TGN. Increased expression of LRP10 in human neuroblastoma SH-SY5Y cells induces the accumulation of mature APP in the Golgi and reduces its presence at the cell surface and its processing into Aβ, while knockdown of LRP10 expression increases Aβ production. Mutations of key motifs responsible for the recycling of LRP10 to the TGN results in the aberrant redistribution of APP with LRP10 to early endosomes and a concomitant increase in APP β-cleavage into Aβ. Furthermore, expression of LRP10 is significantly lower in the post-mortem brain tissues of AD patients, supporting a possible role for LRP10 in AD. Conclusions: The present study identified LRP10 as a novel APP sorting receptor that protects APP from amyloidogenic processing, suggesting that a decrease in LRP10 function may contribute to the pathogenesis of Alzheimer’s disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1750-1326-7-31

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Over-expression of LRP10 in human neuroblastoma SH-Sy5y cells led to accelerated APP transport from TGN to the plasma membrane with increased APP maturation and reduced Aβ production.

    “Over-expression of LRP10 in human neuroblastoma SH-Sy5y cells led to an accelerated APP transport from TGN to the plasma membrane with increased APP maturation and reduced Aβ production [48].”

    From Sex specific molecular networks and key drivers of Alzheimer’s disease (2023) · cites this paper as [48]

    The Results report that LRP10 overexpression in SH-SY5Y cells increased the amount of mature APP and reduced Aβ40 production. But they report APP accumulation in the TGN and less APP at the cell surface, suggesting retention rather than accelerated transport to the plasma membrane. Pulse-chase experiments also found similar maturation kinetics, so the increased mature APP does not establish faster maturation. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • In female APOE4+/- AD brains, reduction in LRP10 protein expression may result in increased Aβ production with impaired APP trafficking as well as reduced Aβ clearance by microglia, leading to AD pathological changes.

    “It is possible that in female APOE4+/- AD brains, reduction in LRP10 protein expression may result in an increased Aβ production with impaired APP trafficking [48] as well as a reduced Aβ clearance by microglia (as supported by our data) leading to AD pathological changes.”
  • LRP10 was previously implicated in APP trafficking and processing, with subcellular localization in the trans-Golgi network (TGN), plasma membrane and endosomes.

    “LRP10 was previously implicated in APP trafficking and processing [48] with a subcellular localization in the trans-Golgi network (TGN), plasma membrane and endosomes.”
  • LRP10 protein levels were previously shown to be significantly lower in the frontal cortex and hippocampus of AD brains than in controls, with a greater extent of reduction in female AD subjects than in male counterparts.

    “The LRP10 protein levels were previously shown to be significantly lower in the frontal cortex and hippocampus of AD brains than those in controls with a greater extent of reduction in female AD subjects than in male counterparts [48].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 31

  1. De Strooper B Annaert W Proteolytic processing and cell biological functions of the amyloid precursor protein J Cell Sci 2000 113 Pt 11 1857 1870 10806097
  2. Marzolo MP Bu G Lipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer's disease Semin Cell Dev Biol 2009 20 191 200 10.1016/j.semcdb.2008.10.005 19041409 PMC2691858 · DOI · Paper page
  3. Wagner T Pietrzik CU The role of lipoprotein receptors on the physiological function of APP Experimental brain research 2012 217 377 387 10.1007/s00221-011-2876-8 21947084 · DOI
  4. Willnow TE The low-density lipoprotein receptor gene family: multiple roles in lipid metabolism J Mol Med (Berl) 1999 77 306 315 10.1007/s001090050356 10090593 · DOI
  5. Ulery PG Beers J Mikhailenko I Tanzi RE Rebeck GW Hyman BT Strickland DK Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease J Biol Chem 2000 275 7410 7415 10.1074/jbc.275.10.7410 10702315 · DOI · Paper page
  6. Jacobsen L Madsen P Nielsen MS Geraerts WP Gliemann J Smit AB Petersen CM The sorLA cytoplasmic domain interacts with GGA1 and −2 and defines minimum requirements for GGA binding FEBS Lett 2002 511 155 158 10.1016/S0014-5793(01)03299-9 11821067 · DOI
  7. Andersen OM Reiche J Schmidt V Gotthardt M Spoelgen R Behlke J von Arnim CA Breiderhoff T Jansen P Wu X Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein Proc Natl Acad Sci USA 2005 102 13461 13466 10.1073/pnas.0503689102 16174740 PMC1224625 · DOI · Paper page
  8. Schmidt V Sporbert A Rohe M Reimer T Rehm A Andersen OM Willnow TE SorLA/LR11 regulates processing of amyloid precursor protein via interaction with adaptors GGA and PACS-1 J Biol Chem 2007 282 32956 32964 10.1074/jbc.M705073200 17855360 · DOI · Paper page
  9. Fjorback AW Seaman M Gustafsen C Mehmedbasic A Gokool S Wu C Militz D Schmidt V Madsen P Nyengaard JR Retromer binds the FANSHY sorting motif in SorLA to regulate amyloid precursor protein sorting and processing J Neurosci 2012 32 1467 1480 10.1523/JNEUROSCI.2272-11.2012 22279231 PMC6796259 · DOI
  10. Scherzer CR Offe K Gearing M Rees HD Fang G Heilman CJ Schaller C Bujo H Levey AI Lah JJ Loss of apolipoprotein E receptor LR11 in Alzheimer disease Arch Neurol 2004 61 1200 1205 10.1001/archneur.61.8.1200 15313836 · DOI · Paper page
  11. Battle MA Maher VM McCormick JJ ST7 is a novel low-density lipoprotein receptor-related protein (LRP) with a cytoplasmic tail that interacts with proteins related to signal transduction pathways Biochemistry 2003 42 7270 7282 10.1021/bi034081y 12809483 · DOI
  12. Boucher R Larkin H Brodeur J Gagnon H Theriault C Lavoie C Intracellular trafficking of LRP9 is dependent on two acidic cluster/dileucine motifs Histochem Cell Biol 2008 130 315 327 10.1007/s00418-008-0436-5 18461348 · DOI
  13. Sugiyama T Kumagai H Morikawa Y Wada Y Sugiyama A Yasuda K Yokoi N Tamura S Kojima T Nosaka T A novel low-density lipoprotein receptor-related protein mediating cellular uptake of apolipoprotein E-enriched beta-VLDL in vitro Biochemistry 2000 39 15817 15825 10.1021/bi001583s 11123907 · DOI
  14. Doray B Knisely JM Wartman L Bu G Kornfeld S Identification of acidic dileucine signals in LRP9 that interact with both GGAs and AP-1/AP-2 Traffic 2008 9 1551 1562 10.1111/j.1600-0854.2008.00786.x 18627575 PMC2892795 · DOI
  15. Tamboli IY Prager K Barth E Heneka M Sandhoff K Walter J Inhibition of glycosphingolipid biosynthesis reduces secretion of the beta-amyloid precursor protein and amyloid beta-peptide J Biol Chem 2005 280 28110 28117 10.1074/jbc.M414525200 15923191 · DOI
  16. Belyaev ND Kellett KA Beckett C Makova NZ Revett TJ Nalivaeva NN Hooper NM Turner AJ The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a {beta}-secretase-dependent pathway J Biol Chem 2010 285 41443 41454 10.1074/jbc.M110.141390 20961856 PMC3009870 · DOI
  17. Kitazume S Tachida Y Kato M Yamaguchi Y Honda T Hashimoto Y Wada Y Saito T Iwata N Saido T Taniguchi N Brain endothelial cells produce amyloid beta from amyloid precursor protein 770 and preferentially secrete the O-glycosylated form J Biol Chem 2010 285 40097 40103 10.1074/jbc.M110.144626 20952385 PMC3000992 · DOI
  18. Fuentealba RA Barria MI Lee J Cam J Araya C Escudero CA Inestrosa NC Bronfman FC Bu G Marzolo MP ApoER2 expression increases Abeta production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulation of gamma-secretase activity Molecular neurodegeneration 2007 2 14 10.1186/1750-1326-2-14 17620134 PMC1939850 · DOI · Paper page
  19. Brodeur J Larkin H Boucher R Theriault C St-Louis SC Gagnon H Lavoie C Calnuc binds to LRP9 and affects its endosomal sorting Traffic 2009 10 1098 1114 10.1111/j.1600-0854.2009.00933.x 19497050 · DOI · Paper page
  20. Parvathy S Hussain I Karran EH Turner AJ Hooper NM Cleavage of Alzheimer's amyloid precursor protein by alpha-secretase occurs at the surface of neuronal cells Biochemistry 1999 38 9728 9734 10.1021/bi9906827 10423252 · DOI
  21. Lleo A Waldron E von Arnim CA Herl L Tangredi MM Peltan ID Strickland DK Koo EH Hyman BT Pietrzik CU Berezovska O Low density lipoprotein receptor-related protein (LRP) interacts with presenilin 1 and is a competitive substrate of the amyloid precursor protein (APP) for gamma-secretase J Biol Chem 2005 280 27303 27309 10.1074/jbc.M413969200 15917251 · DOI
  22. Nyborg AC Ladd TB Zwizinski CW Lah JJ Golde TE Sortilin, SorCS1b, and SorLA Vps10p sorting receptors, are novel gamma-secretase substrates Molecular neurodegeneration 2006 1 3 10.1186/1750-1326-1-3 16930450 PMC1513133 · DOI
  23. Cellini E Tedde A Bagnoli S Pradella S Piacentini S Sorbi S Nacmias B Implication of sex and SORL1 variants in italian patients with Alzheimer disease Arch Neurol 2009 66 1260 1266 10.1001/archneurol.2009.101 19822782 · DOI
  24. Liang X Slifer M Martin ER Schnetz-Boutaud N Bartlett J Anderson B Zuchner S Gwirtsman H Gilbert JR Pericak-Vance MA Haines JL Genomic convergence to identify candidate genes for Alzheimer disease on chromosome 10 Hum Mutat 2009 30 463 471 10.1002/humu.20953 19241460 PMC2713862 · DOI
  25. Lane RF Raines SM Steele JW Ehrlich ME Lah JA Small SA Tanzi RE Attie AD Gandy S Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complex J Neuroscie 2010 30 13110 13115 10.1523/JNEUROSCI.3872-10.2010 PMC3274732 20881129 · DOI
  26. Lin P Li F Zhang YW Huang H Tong G Farquhar MG Xu H Calnuc binds to Alzheimer's beta-amyloid precursor protein and affects its biogenesis J Neurochem 2007 100 1505 1514 17348862
  27. Santosa C Rasche S Barakat A Bellingham SA Ho M Tan J Hill AF Masters CL McLean C Evin G Decreased expression of GGA3 Protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein Neurobiol Dis 2011 43 176 183 10.1016/j.nbd.2011.03.009 21440067 · DOI
  28. Wahle T Thal DR Sastre M Rentmeister A Bogdanovic N Famulok M Heneka MT Walter J GGA1 is expressed in the human brain and affects the generation of amyloid beta-peptide Jo Neurosci 2006 26 12838 12846 10.1523/JNEUROSCI.1982-06.2006 PMC6674839 17151287 · DOI
  29. Icking A Amaddii M Ruonala M Honing S Tikkanen R Polarized transport of Alzheimer amyloid precursor protein is mediated by adaptor protein complex AP1-1B Traffic 2007 8 285 296 10.1111/j.1600-0854.2006.00526.x 17319802 · DOI
  30. Gebhardt FM Scott HA Dodd PR Housekeepers for accurate transcript expression analysis in Alzheimer's disease autopsy brain tissue Alzheimers Dement 2010 6 465 474 10.1016/j.jalz.2009.11.002 21044776 · DOI
  31. Livak KJ Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method Methods 2001 25 402 408 10.1006/meth.2001.1262 11846609 · DOI · Paper page

Cited by

Sorted by citations

Authors
Brodeur, J., Thériault, C., Lessard-Beaudoin, M., Marcil, A., Dahan, S., & Lavoie, C.
Affiliations
  • Université de Sherbrooke (CA)
  • PerkinElmer Biosignal (CA)
Corresponding author
Lavoie, Christine
Venue
Molecular Neurodegeneration
Published
2012-06-26
Volume
7
Issue
1
Pages
31-31
ISSN
1750-1326 (ISSN-L)
OpenAlex
W2129354516
Cited by
77
References
2
Citations by year
2026: 2 · 2025: 2 · 2024: 22 · 2023: 4 · 2022: 3 · 2021: 6 · 2020: 8 · 2019: 7 · 2018: 4 · 2017: 5 · 2016: 3 · 2015: 3 · 2014: 8
FWCI
2.36
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Molecular Neurodegeneration (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Alzheimer Society
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
amyloid precursor protein, APP trafficking, amyloid-beta production, trans-Golgi network, endosomes, Alzheimer's disease
MeSH terms
Alzheimer Disease, Animals, Cell Membrane, Cells, Cultured, Golgi Apparatus, Humans, Protein Processing, Post-Translational, Endosomes, Amyloid beta-Protein Precursor, Protein Transport, trans-Golgi Network, LDL-Receptor Related Proteins, Mice, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review